HEOR: From Proving Product Value to Proving Its Own Worth
Published: | Updated:
The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Sissi Pham
Advertisement
Sissi Pham, PharmD, is the CEO of AESARA Inc.
Articles by Sissi Pham
Advertisement
Latest Updated Articles
HEOR: From Proving Product Value to Proving Its Own WorthPublished: March 6th 2025 | Updated: May 7th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
What Does the Rollout of Trump Rx Reveal?
5